Chris Van Hollen Stock Trades

Chris Van Hollen Trading Disclosures | Quantellect Chris Van Hollen Trading Disclosures | Quantellect

Chris Van Hollen's disclosure record is short, dated, and one-directional. Across thirteen transactions disclosed between 2015 and 2017, every single one was a sale. Not one purchase appears anywhere in the record. For a sitting Maryland senator, the picture on file is narrow: the disclosed activity runs from February 5, 2015, through February 17, 2017, which remains the latest transaction date in the data.

The most recent disclosed activity groups tightly around February 17, 2017, when seven separate sales were reported in a single filing dated March 13, 2017, covering GE Aerospace, AT&T, Yum! Brands, PepsiCo, Johnson & Johnson, Yum China Holdings, and Verizon. Every one of those transactions was marked a "Sale (Full)." The GE and PepsiCo sales were each disclosed in the $15,001–$50,000 range, while the other five were each in the $1,001–$15,000 range. Seven full-sale entries on the same date form a distinct cluster rather than a series of incremental adjustments.

Before that cluster, the record shows a smaller wave of four sales across December 5 and 6, 2016: PepsiCo, an untickered Comcast Corp entry, GE, and Johnson & Johnson, all disclosed together on December 23, 2016. The PepsiCo, GE, and Johnson & Johnson sales were each reported in the $1,001–$15,000 range, while Comcast was reported at $15,001–$50,000. A Colgate-Palmolive sale dated August 25, 2016, was disclosed on September 13 in the $15,001–$50,000 range. The earliest transaction on file is a Pfizer sale dated February 5, 2015, disclosed under Joint attribution rather than confirmed as Van Hollen's sole activity. The other twelve transactions carry Self attribution.

Van Hollen's disclosed trading centers on recognizable consumer, communications, health-care, and industrial names. By transaction-row count, GE (GE), Johnson & Johnson (JNJ), and PepsiCo (PEP) are the most frequently disclosed securities, with two sales apiece. AT&T and Verizon each appear once, were both sold on February 17, 2017, and are both classified under Communication Services. Yum! Brands and Yum China Holdings also appear as separate full sales on that date, with both classified under Consumer Discretionary. The common timing is clear from the disclosure; the record does not establish why the securities were sold together.

Sector spread and what the disclosed names do

By transaction count, Consumer Staples leads the disclosed activity with three sales, PepsiCo twice and Colgate-Palmolive once, followed by Communication Services, Consumer Discretionary, Health Care, and Industrials with two transactions apiece. Two additional transactions carry no sector classification in the data because the Comcast and Pfizer entries lack ticker-linked company detail. That spread across communications, health care, consumer products, restaurants, and aerospace does not point to activity concentrated in a single sector. It reads as a broad round of sales distributed across several established industries.

The underlying businesses themselves are recognizable market names rather than niche or emerging companies. GE Aerospace designs and produces commercial and military aircraft engines and related systems. Johnson & Johnson spans pharmaceuticals and medical technology. PepsiCo manufactures and sells beverages and convenient foods, while Colgate-Palmolive sells oral-care, personal-care, home-care, and pet-nutrition products. AT&T and Verizon provide communications services that include wireless and wireline offerings. Yum! Brands develops, operates, and franchises restaurant concepts including KFC, Taco Bell, Pizza Hut, and Habit Burger & Grill, while Yum China operates and franchises restaurants in China under concepts including KFC, Pizza Hut, and Taco Bell. Together, the disclosed securities span mature businesses across several sectors rather than a narrow thematic category.

Attribution matters here. Twelve of the thirteen transactions are labeled "Self," meaning they were reported with Self attribution for Van Hollen. The 2015 Pfizer sale is labeled "Joint," distinguishing it from the twelve Self entries without identifying it as solely his activity. No transactions in this record are attributed to a spouse, dependent child, or unknown party.

Taken as a whole, the filings describe thirteen disclosed sales dated from February 5, 2015, through February 17, 2017, with no purchases in the record. The annual sequence consists of one sale in 2015, five in 2016, and seven in 2017. As measured on August 22, 2026, Quantellect tracks 537 sitting members of Congress, 276 of whom have no disclosed trades. Van Hollen is among the members with at least some public transaction activity, although the latest transaction date in this record remains February 17, 2017.

About this data

This Quantellect profile is built from official congressional financial disclosure filings required under the Stop Trading on Congressional Knowledge Act of 2012. The transactions referenced here appear in Van Hollen's official filings from 2015, September 2016, December 2016, and March 2017. Transaction amounts in this profile are disclosed ranges rather than exact figures. Additional guidance on the disclosure process is available from the Senate Select Committee on Ethics. This profile reflects transactions as disclosed and does not represent investment advice or a complete record of any individual's finances.